6 results
10-K
2019 FY
ARCT
Arcturus Therapeutics Holdings Inc
16 Mar 20
Annual report
11:09am
to generate a library of proprietary biodegradable lipids.
The STARR technology platform combines self-replicating RNA with LUNAR, a proprietary … and more rapidly biodegradable lipids. The Company has developed processes for the scale up of LNP-mRNA therapeutics to support clinical development
424B3
Arcturus Therapeutics Holdings, Inc.
12 Apr 19
Prospectus supplement
4:39pm
. These delivery systems are not biodegradable, which causes accumulation of these lipids in cells upon repeat dosing. Each of these aspects of current … and biodegradable lipids. The Company has developed processes for the scale up ofLNP-mRNA therapeutics to support clinical development.
mRNA therapeutics
S-4/A
Arcturus Therapeutics Holdings, Inc.
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
are not biodegradable, which causes accumulation of these lipids in cells upon repeat dosing. Each of these aspects of current lipid nanoparticle delivery … and tolerability issues associated with the LNP mRNA delivery with the development of both less immunogenic mRNAs and biodegradable lipids
S-4
m1u2u
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next